ADPT
ADPT
US00650F1093
Adaptive Biotechnologies Corpor
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
4.23B EUR
3.41B EUR
2.22B EUR
2.5B EUR
Enterprise Value
4.24B EUR
3.65B EUR
2.22B EUR
2.51B EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-146.8x
--
--
--
Price to Sales
13.72x
11.07x
7.5x
11.12x
Price to Book
29.5x
23.87x
10.25x
11.41x
EV/Revenue
13.76x
11.86x
7.5x
11.16x
EV/EBITDA
-198.71x
--
--
--
Price to FCF (P/FCF)
222.78x
--
--
--
EV/FCF
223.32x
--
--
--
FCF Yield
0.45%
-0.7%
-1.33%
-0.77%
ende